Варіанти перебігу і ведення пацієнтів з персистентною фібриляцією передсердь

Я.В. Скибчик, К.О. Міхалєв, О.Й. Жарінов

Література

1. Fibrylyatsiya i tripotinnya peredserdʹ / Za red. O.Y. Zharinova, V.O. Kutsya .– K.: Chetverta khvylya, 2022.– 248 s.
2. Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453-68. doi: 10.1161/CIRCRESAHA.114.303211. PMID: 24763464.
3. Berger WR, Meulendijks ER, Limpens J, et al. Persistent atrial fibrillation: A systematic review and meta-analysis of invasive strategies. Int J Cardiol. 2019;278:137-43. doi: 10.1016/j.ijcard.2018.11.127. Epub 2018 Nov 29. PMID: 30553497.
4. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2019;74(1):104-32 .
5. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. EP Europace. 2018;20(1):e1-e160. doi: 10.1016/0735-1097(91)90592-w.
6. Camm AJ, Naccarelli GV, Mittal S, et al. The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(19):1932-48. doi: 10.1016/j.jacc.2022.03.337. PMID: 35550691.
7. Cochet H, Mouries A, Nivet H, et al. Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol. 2015;26(5):484-92. doi: 10.1111/jce.12651. Epub 2015 Apr 22. PMID: 25727248.
8. Deshmukh A, Barnard J, Sun H, et al. Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence. Circ Arrhythm Electrophysiol. 2015;8(1):32-41. doi: 10.1161/CIRCEP.114.001632. Epub 2014 Dec 18. PMID: 25523945; PMCID: PMC433469.
9. Fosbol EL, Holmes DN, Piccini JP, et al. Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry. J Am Heart Assoc. 2013;2(4):e000110. doi: 10.1161/JAHA.113.000110. PMID: 23868192; PMCID: PMC3828776.
10. Goette A, Kalman J, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterization, and clinical implication. EP Europace. 2016;18(10):1455-90. doi: 10.1007/s10840-012-9727-9
11. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659-66. doi: 10.1056/NEJM199809033391003. PMID: 9725923.
12. Heijman J, Hohnloser S, Camm J, et al. Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future. EP Europace. 2021;23(2): ii14–ii22, https://doi.org/10.1093/europace/euaa426.
13. Hindricks G, Potpara Т, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020;42(5):373-498. doi: 10.1007/s12410-019-9520-6.
14. Imberti JF, Ding WY, Kotalczyk A, et al. Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Heart. 2021;107:1630-6.
15. Kirchhof P, Camm AJ, Goette A, et al. EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305-16. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29. PMID: 32865375.
16. Kirchhof P, Ammentorp B, Darius H, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events – European Registry in Atrial Fibrillation (PREFER in AF). EP Europace. 2014;16(1);6-14. https://doi.org/10.1093/europace/eut263
17. Konrad T, Theis C, Mollnau H, Sonnenschein S, Ocete BQ, Bock K, Münzel T, Rostock T. Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population. J Cardiovasc Electrophysiol. 2015;26(12):1289-94. doi: 10.1111/jce.12818. Epub 2015 Oct 12. PMID: 26303513.
18. Kordík P, Křemen V, Lhotska L. The GAME Algorithm Applied to Complex Fractionated Atrial Electrograms Data Set. 1970;5164:859-68. doi: 10.1007/978-3-540-87559-8_89.
19. Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J Cardiovasc Electrophysiol. 2012;23(7):797-9. doi: 10.1111/j.1540-8167.2012.02341.x. Epub 2012 May 3. PMID: 22554187.
20. Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur Heart J. 2013;34(35):2731-8. doi: 10.1093/eurheartj/eht194. Epub 2013 Jun 11. PMID: 23761394.
21. Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation: how to modify the substrate? J Am Coll Cardiol. 2015;65(2):196-206. doi: 10.1016/j.jacc.2014.10.034. PMID: 25593061.
22. Lim H, Denis A, Middeldorp M, et al. Persistent Atrial Fibrillation From the Onset: A Specific Subgroup of Patients With Biatrial Substrate Involvement and Poorer Clinical Outcome. JACC: Clinical Electrophysiology. 2016;2(2):129-39. doi: 10.1016/j.jacep.2016.02.010.
23. Lo LW, Tai CT, Lin YJ, et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm. 2009;6(3):311-8. doi: 10.1016/j.hrthm.2008.11.013. Epub 2008 Nov 19. PMID: 19251203.
24. Magnocavallo M, Parlavecchio A, Vetta G, et al. Catheter Ablation versus Medical Therapy of Atrial Fibrillation in Patients with Heart Failure: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2022;11(19):5530. doi: 10.3390/jcm11195530. PMID: 36233407; PMCID: PMC9572511.
25. Mark D.B, Anstrom K.J, Sheng S et al. Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321:1275-85.
26. Marrouche NF, Brachmann J, Andresen D et al.; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417-27.
27. Martins RP. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014;129(14):1472-82.
28. Mody BP, Raza A, Jacobson J, et al. Ablation of long-standing persistent atrial fibrillation. Ann Transl Med. 2017;5(15):305. doi: 10.21037/atm.2017.05.21. PMID: 28856145; PMCID: PMC5555980.
29. Moe GK, Abildskov JA. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J. 1959;58(1):59-70. doi: 10.1016/0002-8703(59)90274-1.PMID: 13661062.
30. Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J. 2012;33(15):1870-7. doi: 10.1093/eurheartj/ehs079. Epub 2012 Apr 16. PMID: 22507975.
31. Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63(22):2335-45. doi: 10.1016/j.jacc.2014.02.555. Epub 2014 Mar 19. PMID: 24613319.
32. Nattel S. Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms. Can J Cardiol. 2013;29(10):1147-9.
33. Oliveira IM, Oliveira BD, et al. Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. Cardiovasc Pathol. 2013;22(1):65-9. doi: 10.1016/j.carpath.2012.06.001. Epub 2012 Aug 20. PMID: 22917538.
34. Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58(21):2225-32. doi: 10.1016/j.jacc.2011.05.061. PMID: 22078429.
35. Scherr D, Khairy P, Miyazaki S, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18-24. doi: 10.1161/CIRCEP.114.001943. Epub 2014 Dec 20. PMID: 25528745.
36. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, et al. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog Cardiovasc Dis. 2005;48(3):153-68.
37. Steffel J, Collins R, Matthias Antz, at al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Europace. 2021;23(10):1612-76. https://doi.org/10.1093/europace/euab065
38. Steinberg BA, Hellkamp AS, Lokhnygina Y, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET- AF trial. Eur Heart J. 2015;36:288-96.
39. Um KJ, McIntyre WF, Healey JS, et al. Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis. Europace. 2019;21(6):856-63. doi: 10.1093/europace/euy310.
40. Verma A, Jiang CY, Betts TR, et al. STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812-22. doi: 10.1056/NEJMoa1408288. PMID: 25946280.
41. Wei SK, Ruknudin AM, Shou M, et al. Muscarinic modulation of the sodium-calcium exchanger in heart failure. Circulation. 2007;115(10):1225-33. doi:10.1161/CIRCULATIONAHA.106.650416. Epub 2007 Mar 5. PMID: 17339552.
42. Wijffels MC, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation. 1995;92(7):1954-68.
43. Zoni-Berisso M, Lercari Y, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. J. Clin. Epidemiol. 2014;(6):213–20.